John Hsiao - Concepedia

Author

John Hsiao

National Institute of Mental Health ORCID

Also Known As

Carole Ho, Genetics Core Leaders and Key Personnel, Isabella Hoang, J Hsiao, J K Hsiao, J. Hsiao, J. K. HSIAO, J. K. Hsiao, J. Kent Hsiao, J.K Hsiao

196

Publications

19.9K

Citations

H-Index

123

Concepts

All Affiliations

National Institute of Mental Health University of North Carolina at Chapel Hill National Institutes of Health Duke University Columbia University

About

John Hsiao is an author at National Institute of Mental Health specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	35	4.8K
2	Social Sciences	20	23	3.4K
3	Health Sciences	4	4	372
4	Engineering	2	2	188
5	Education	1	1	56

John Hsiao

Publications

14.6K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, New England Journal of Medicine	2005	5.9K
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, New England Journal of Medicine	2006	1.2K
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff, Schizophrenia Research Intervention EffectivenessMetabolic SyndromeMetabolic DisorderPsychiatryPsychotic Disorder	2005	1.1K
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup, American Journal of Psychiatry PsychiatryPsychotic DisorderPsychotropic MedicationRebound EffectClinical Trials	2006	748
Barriers to Employment for People With Schizophrenia Robert A. Rosenheck, Douglas Leslie, Richard S.E. Keefe, American Journal of Psychiatry	2006	463
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial David L. Sultzer, Sonia M. Davis, Pierre N. Tariot, American Journal of Psychiatry	2008	315
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic T. Scott Stroup, Jeffrey A. Lieberman, Joseph P. McEvoy, American Journal of Psychiatry Intervention EffectivenessPrevious Atypical AntipsychoticPsychiatryPsychotic DisorderPsychotropic Medication	2006	301
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1 Jonathan M. Meyer, Vicki G. Davis, Donald Goff, Schizophrenia Research Catie Schizophrenia TrialMetabolic SyndromePsychiatryPsychotic DisorderPsychotropic Medication	2008	285
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study Marvin S. Swartz, Diana O. Perkins, T. Scott Stroup, American Journal of Psychiatry	2007	283
Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD Cheryl Vigen, Wendy J. Mack, Richard S.E. Keefe, American Journal of Psychiatry	2011	282

Page 1